Key Highlights
- Precision Optics (NASDAQ:POCI) reported fiscal first-quarter Revenue of USD 8,152,083, up 22.0% from USD 6,680,823 in the quarter ended September 30, 2025.
- Gross Margin rose to 22.5% from 14.2%, and Gross Profit climbed to USD 1,837,851 from USD 946,358.
- Net loss narrowed to USD 474,854, or USD 0.04 a share, from USD 1,637,030, or USD 0.21 a share, a calculated improvement of about 71%.
- Cash and cash equivalents were USD 8,966,889 at September 30, 2026, down from USD 9,841,142 at June 30, 2026, with a USD 2.0 million minimum Liquidity covenant.
Systems Manufacturing and MicroOptics Lab Drive a 22.0% Revenue Gain
Precision Optics (NASDAQ:POCI) designs and makes ultra-high precision endoscopes and very small lenses, assemblies and complete devices for minimally invasive surgery, and also serves defense and aerospace customers. Its quarterly report, filed November 16, 2026, shows total revenue of USD 8,152,083 for the fiscal first quarter, an increase of USD 1,471,260 from a year earlier.
Systems Manufacturing, the largest line at 71.0% of sales, grew 18.9% to USD 5,785,153 on higher customer Demand and the scaling of production. The MicroOptics Lab more than tripled, rising 204.7% to USD 305,806, helped by new orders from a defense customer. Ross Optical Industries rose 26.0% to USD 1,332,658, which the company attributes to less Tariff uncertainty, and Engineering Design Services gained 11.0% to USD 728,466 on better utilization.
Yields, Royalties and Lower Severance Narrow the Loss
Gross margin expanded to 22.5% from 14.2%, with the company crediting higher Ross Optical and MicroOptics Lab revenue, better yields on manufacturing lines and increased royalties. Research and Development spending was almost flat at USD 306,215, a decline of USD 5,625. Selling, general and administrative expenses fell 8.1% to USD 2,049,946, mainly on lower severance and a gain on the sale of equipment.
Interest expense dropped to USD 30,121 from USD 41,775 as term note balances shrank, while interest income was USD 73,577 against none a year earlier, reflecting cash raised in a March 2026 public offering. Net loss came in at USD 474,854, compared with USD 1,637,030 in the same period a year ago.
Cash Dips and a New Liquidity Covenant Replaces the Coverage Test
Operating activities used USD 672,145 of cash in the quarter, against USD 78,227 provided a year earlier, mainly because of lower Accounts Payable and the net loss, partly offset by reductions in receivables and inventory. Investing used USD 48,025, and financing used USD 154,083, including USD 149,083 of term note payments. Cash fell by USD 874,253 over the quarter.
On September 25, 2026, the lender waived the Debt service coverage covenant for fiscal 2026 and replaced it with a USD 2.0 million minimum liquidity covenant, while granting USD 750,000 of revolver availability, expandable to USD 1,250,000 if coverage reaches 1.2x. There were no revolver borrowings at quarter end, and the company met the covenant. Open purchase orders totaled about USD 4,230,000, and shares outstanding were 10,994,430 as of November 12, 2026.
Where Things Stand
The quarter showed Operating Leverage returning at a small scale. Precision Optics (NASDAQ:POCI) grew revenue 22.0%, nearly doubled gross profit and cut its loss to USD 0.47 million, yet Operating Cash Flow turned negative and cash slipped to USD 9.0 million. Management believes cash, operations, the Credit line and Capital market access cover at least twelve months, while acknowledging it may need outside financing. Watch for margin durability, further defense orders at the MicroOptics Lab, Working Capital swings and compliance with the liquidity covenant.






Please wait processing your request...